Comment Vol 377 February 12, 2011 Stemming the global tsunami of cardiovascular disease.

CommentComment

www.thelancet.com www.thelancet.com Vol 377 February 12, 2011

Stemming the global tsunami of cardiovascular Stemming the global tsunami of cardiovascular diseasedisease

An epidemic of risk factors for cardiovascular disease

The Lancet, Volume 377, Issue 9765, Page 527, 12 February 2011

INFLAMACION Y ENFERMEDAD CARDIOVASCULAR

CRP: star trekking the galaxy of risk markers

Editorial

C reactive protein and the risk of cardiovascular disease

C reactive protein and the risk of cardiovascular disease

Are clearly linked but a causal association is unlikely

Editorial

Figure 2

MICROBIOMA HUMANO

Y ENFERMEDAD CARDIOVASCULAR

LDL Y ENFERMEDAD CARDIOVASCULAR:

MÁS ALLÁ DE LAS ESTATINAS

HDL Y ENFERMEDAD CARDIOVASCULAR

HDL and Cardiovascular-Disease Risk — Time for a New Approach?

N Engl J Med 2011; 364:170-171 January 13, 2011

Editorial

Jay Heinecke, M.D.

Clinical Implications of Basic Research

Sorting Out Cholesterol and Coronary Artery Disease

Patrick Linsel-Nitschke, M.D., Nilesh J. Samani, M.D., M.B., Ch.B., and Heribert Schunkert, M.D.

N Engl J Med 2010; 363:2462-2463

Sortilin 1 and the Risk of Coronary Disease.

Linsel-Nitschke P et al. N Engl J Med 2010;363:2462-2463.

EPIGENÉTICA Y ENFERMEDAD CARDIOVASCULAR

INSULINORESISTENCIA Y ENFERMEDAD CARDIOVASCULAR

A Comparison of PPARγ Activity in Lean and Obese Persons.

Kahn BB, McGraw TE. N Engl J Med 2010;363:2667-2669.

NUTRICIÓN Y ENFERMEDAD CARDIOVASCULAR

Volume 362:2102-2112 June 3, 2010 Number 22

REPROGRAMACIÓN CELULAR Y ENFERMEDAD CARDIOVASCULAR

Clinical Implications of Basic Research

Reprogramming Fibroblasts into Cardiomyocytes

Charles E. Murry, M.D., Ph.D., and William T. Pu, M.D.

N Engl J Med 2011; 364:177-17

The Path from Fibroblast to Cardiomyocyte.

Murry CE, Pu WT. N Engl J Med 2011;364:177-178.

LA POBREZA Y ENFERMEDAD CARDIOVASCULAR